HEADER VIRAL PROTEIN 08-OCT-23 8WOX TITLE CRYO-EM STRUCTURE OF SARS-COV-2 PROTOTYPE RBD IN COMPLEX WITH RABBIT TITLE 2 ACE2 (LOCAL REFINEMENT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S1; COMPND 3 CHAIN: B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANGIOTENSIN-CONVERTING ENZYME; COMPND 7 CHAIN: A; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: S, 2; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 11 ORGANISM_COMMON: RABBIT; SOURCE 12 ORGANISM_TAXID: 9986; SOURCE 13 GENE: ACE2; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SARS-COV-2 OMICRON, RECEPTOR-BINDING DOMAINS (RBDS), RABBIT, KEYWDS 2 ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2), VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR L.J.LI,K.Y.SHI,G.H.YU,G.F.GAO REVDAT 3 28-FEB-24 8WOX 1 JRNL REVDAT 2 03-JAN-24 8WOX 1 JRNL REVDAT 1 13-DEC-23 8WOX 0 JRNL AUTH K.SHI,L.LI,C.LUO,Z.XU,B.HUANG,S.MA,K.LIU,G.YU,G.F.GAO JRNL TITL STRUCTURAL BASIS OF INCREASED BINDING AFFINITIES OF SPIKES JRNL TITL 2 FROM SARS-COV-2 OMICRON VARIANTS TO RABBIT AND HARE ACE2S JRNL TITL 3 REVEALS THE EXPANDING HOST TENDENCY. JRNL REF MBIO V. 15 98823 2024 JRNL REFN ESSN 2150-7511 JRNL PMID 38112468 JRNL DOI 10.1128/MBIO.02988-23 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.750 REMARK 3 NUMBER OF PARTICLES : 350247 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WOX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 11-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1300041687. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SARS-COV-2 PROTOTYPE SPIKE REMARK 245 PROTEIN IN COMPLEX WITH RABBIT REMARK 245 ACE2 (LOCAL REFINED) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG B 319 REMARK 465 VAL B 320 REMARK 465 GLN B 321 REMARK 465 PRO B 322 REMARK 465 THR B 323 REMARK 465 GLU B 324 REMARK 465 SER B 325 REMARK 465 ILE B 326 REMARK 465 VAL B 327 REMARK 465 ARG B 328 REMARK 465 PHE B 329 REMARK 465 PRO B 330 REMARK 465 ASN B 331 REMARK 465 ILE B 332 REMARK 465 THR B 333 REMARK 465 ASN B 334 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 THR B 531 REMARK 465 ASN B 532 REMARK 465 LEU B 533 REMARK 465 VAL B 534 REMARK 465 LYS B 535 REMARK 465 ASN B 536 REMARK 465 LYS B 537 REMARK 465 CYS B 538 REMARK 465 VAL B 539 REMARK 465 ASN B 540 REMARK 465 PHE B 541 REMARK 465 HIS B 542 REMARK 465 HIS B 543 REMARK 465 HIS B 544 REMARK 465 HIS B 545 REMARK 465 HIS B 546 REMARK 465 HIS B 547 REMARK 465 CYS A 133 REMARK 465 ASN A 134 REMARK 465 GLN A 135 REMARK 465 SER A 136 REMARK 465 ASN A 137 REMARK 465 PRO A 138 REMARK 465 GLN A 139 REMARK 465 GLU A 140 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA B 352 57.83 -97.57 REMARK 500 ARG B 403 -169.08 -78.94 REMARK 500 SER A 109 143.74 -172.62 REMARK 500 ASN A 195 -3.87 69.41 REMARK 500 ALA A 212 -167.51 -77.59 REMARK 500 VAL A 573 -51.32 -121.25 REMARK 500 ASN A 601 50.95 -93.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 374 NE2 REMARK 620 2 HIS A 378 NE2 106.4 REMARK 620 3 GLU A 402 OE1 67.8 83.4 REMARK 620 4 GLU A 402 OE2 113.8 108.3 62.7 REMARK 620 N 1 2 3 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37701 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF SARS-COV-2 PROTOTYPE RBD IN COMPLEX WITH REMARK 900 RABBIT ACE2 (LOCAL REFINEMENT) DBREF 8WOX B 319 541 UNP P0DTC2 SPIKE_SARS2 319 541 DBREF 8WOX A 19 614 UNP G1TEF4 G1TEF4_RABIT 19 614 SEQADV 8WOX HIS B 542 UNP P0DTC2 EXPRESSION TAG SEQADV 8WOX HIS B 543 UNP P0DTC2 EXPRESSION TAG SEQADV 8WOX HIS B 544 UNP P0DTC2 EXPRESSION TAG SEQADV 8WOX HIS B 545 UNP P0DTC2 EXPRESSION TAG SEQADV 8WOX HIS B 546 UNP P0DTC2 EXPRESSION TAG SEQADV 8WOX HIS B 547 UNP P0DTC2 EXPRESSION TAG SEQRES 1 B 229 ARG VAL GLN PRO THR GLU SER ILE VAL ARG PHE PRO ASN SEQRES 2 B 229 ILE THR ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA SEQRES 3 B 229 THR ARG PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG SEQRES 4 B 229 ILE SER ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SEQRES 5 B 229 SER ALA SER PHE SER THR PHE LYS CYS TYR GLY VAL SER SEQRES 6 B 229 PRO THR LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR SEQRES 7 B 229 ALA ASP SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN SEQRES 8 B 229 ILE ALA PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN SEQRES 9 B 229 TYR LYS LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA SEQRES 10 B 229 TRP ASN SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN SEQRES 11 B 229 TYR ASN TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU SEQRES 12 B 229 LYS PRO PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN SEQRES 13 B 229 ALA GLY SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN SEQRES 14 B 229 CYS TYR PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR SEQRES 15 B 229 ASN GLY VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SEQRES 16 B 229 SER PHE GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY SEQRES 17 B 229 PRO LYS LYS SER THR ASN LEU VAL LYS ASN LYS CYS VAL SEQRES 18 B 229 ASN PHE HIS HIS HIS HIS HIS HIS SEQRES 1 A 596 SER THR ILE GLU GLU LEU ALA LYS THR PHE LEU GLU LYS SEQRES 2 A 596 PHE ASN GLN GLU ALA GLU ASP LEU SER TYR GLN SER ALA SEQRES 3 A 596 LEU ALA SER TRP ASP TYR ASN THR ASN ILE THR GLU GLU SEQRES 4 A 596 ASN VAL GLN LYS MET ASN ASP ALA GLU ALA LYS TRP SER SEQRES 5 A 596 ALA PHE TYR GLU GLU GLN SER LYS LEU ALA LYS THR TYR SEQRES 6 A 596 PRO SER GLN GLU VAL GLN ASN LEU THR VAL LYS ARG GLN SEQRES 7 A 596 LEU GLN ALA LEU GLN GLN SER GLY SER SER ALA LEU SER SEQRES 8 A 596 ALA ASP LYS SER LYS GLN LEU ASN THR ILE LEU SER THR SEQRES 9 A 596 MET SER THR ILE TYR SER THR GLY LYS VAL CYS ASN GLN SEQRES 10 A 596 SER ASN PRO GLN GLU CYS PHE LEU LEU GLU PRO GLY LEU SEQRES 11 A 596 ASP GLU ILE MET ALA LYS SER THR ASP TYR ASN GLU ARG SEQRES 12 A 596 LEU TRP ALA TRP GLU GLY TRP ARG SER VAL VAL GLY LYS SEQRES 13 A 596 GLN LEU ARG PRO LEU TYR GLU GLU TYR VAL VAL LEU LYS SEQRES 14 A 596 ASN GLU MET ALA ARG ALA ASN ASN TYR GLU ASP TYR GLY SEQRES 15 A 596 ASP TYR TRP ARG ALA ASP TYR GLU ALA GLU GLY ALA ASP SEQRES 16 A 596 GLY TYR ASP TYR SER ARG SER GLN LEU ILE ASP ASP VAL SEQRES 17 A 596 GLU ARG THR PHE SER GLU ILE LYS PRO LEU TYR GLU GLN SEQRES 18 A 596 LEU HIS ALA PHE VAL ARG THR LYS LEU MET ASP ALA TYR SEQRES 19 A 596 PRO SER ARG ILE SER PRO THR GLY CYS LEU PRO ALA HIS SEQRES 20 A 596 LEU LEU GLY ASP MET TRP GLY ARG PHE TRP THR ASN LEU SEQRES 21 A 596 TYR SER LEU THR VAL PRO PHE GLY GLN LYS PRO ASN ILE SEQRES 22 A 596 ASP VAL THR ASP THR MET VAL ASN GLN GLY TRP ASP ALA SEQRES 23 A 596 GLU ARG ILE PHE LYS GLU ALA GLU LYS PHE PHE VAL SER SEQRES 24 A 596 VAL GLY LEU PRO SER MET THR GLN GLY PHE TRP GLU ASN SEQRES 25 A 596 SER MET LEU THR GLU PRO GLY ASP GLY ARG LYS VAL VAL SEQRES 26 A 596 CYS HIS PRO THR ALA TRP ASP LEU GLY LYS GLY ASP PHE SEQRES 27 A 596 ARG ILE LYS MET CYS THR LYS VAL THR MET ASP ASN PHE SEQRES 28 A 596 LEU THR ALA HIS HIS GLU MET GLY HIS ILE GLN TYR ASP SEQRES 29 A 596 MET ALA TYR ALA THR GLN PRO PHE LEU LEU ARG ASN GLY SEQRES 30 A 596 ALA ASN GLU GLY PHE HIS GLU ALA VAL GLY GLU ILE MET SEQRES 31 A 596 SER LEU SER ALA ALA THR PRO GLU HIS LEU LYS SER ILE SEQRES 32 A 596 GLY LEU LEU PRO TYR ASP PHE HIS GLU ASP ASN GLU THR SEQRES 33 A 596 GLU ILE ASN PHE LEU LEU LYS GLN ALA LEU THR ILE VAL SEQRES 34 A 596 GLY THR LEU PRO PHE THR TYR MET LEU GLU LYS TRP ARG SEQRES 35 A 596 TRP MET VAL PHE LYS GLY GLU ILE PRO LYS GLU GLN TRP SEQRES 36 A 596 MET GLN LYS TRP TRP GLU MET LYS ARG GLU ILE VAL GLY SEQRES 37 A 596 VAL VAL GLU PRO MET PRO HIS ASP GLU THR TYR CYS ASP SEQRES 38 A 596 PRO ALA ALA LEU PHE HIS VAL ALA ASN ASP TYR SER PHE SEQRES 39 A 596 ILE ARG TYR TYR THR ARG THR ILE TYR GLN PHE GLN PHE SEQRES 40 A 596 GLN GLU ALA LEU CYS GLN ALA ALA GLN HIS GLU GLY PRO SEQRES 41 A 596 LEU HIS LYS CYS ASP ILE SER ASN SER THR GLU ALA GLY SEQRES 42 A 596 GLN LYS LEU LEU ASN MET LEU ARG LEU GLY ARG SER GLU SEQRES 43 A 596 PRO TRP THR LEU ALA LEU GLU ASN VAL VAL GLY ALA LYS SEQRES 44 A 596 ASN MET ASP VAL ARG PRO LEU LEU ASN TYR PHE GLU PRO SEQRES 45 A 596 LEU PHE THR TRP LEU LYS GLU GLN ASN ARG ASN SER PHE SEQRES 46 A 596 VAL GLY TRP SER THR GLU TRP THR PRO TYR ALA HET NAG B 601 14 HET ZN A 701 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG C8 H15 N O6 FORMUL 4 ZN ZN 2+ HELIX 1 AA1 PHE B 338 ASN B 343 1 6 HELIX 2 AA2 TYR B 365 ASN B 370 1 6 HELIX 3 AA3 PRO B 384 ASP B 389 5 6 HELIX 4 AA4 GLU B 406 ILE B 410 5 5 HELIX 5 AA5 LYS B 417 ASN B 422 1 6 HELIX 6 AA6 THR A 20 ASN A 53 1 34 HELIX 7 AA7 GLU A 57 ALA A 80 1 24 HELIX 8 AA8 ASN A 90 SER A 103 1 14 HELIX 9 AA9 SER A 109 THR A 129 1 21 HELIX 10 AB1 LEU A 143 SER A 155 1 13 HELIX 11 AB2 ASP A 157 VAL A 172 1 16 HELIX 12 AB3 GLY A 173 GLN A 175 5 3 HELIX 13 AB4 LEU A 176 ASN A 194 1 19 HELIX 14 AB5 ASP A 198 ARG A 204 1 7 HELIX 15 AB6 ALA A 205 GLU A 208 5 4 HELIX 16 AB7 ALA A 212 ASP A 216 5 5 HELIX 17 AB8 SER A 218 TYR A 252 1 35 HELIX 18 AB9 HIS A 265 LEU A 267 5 3 HELIX 19 AC1 TRP A 275 TYR A 279 5 5 HELIX 20 AC2 VAL A 293 GLY A 301 1 9 HELIX 21 AC3 ASP A 303 SER A 317 1 15 HELIX 22 AC4 THR A 324 SER A 331 1 8 HELIX 23 AC5 THR A 365 TYR A 385 1 21 HELIX 24 AC6 PRO A 389 ARG A 393 5 5 HELIX 25 AC7 GLY A 399 ALA A 413 1 15 HELIX 26 AC8 THR A 414 ILE A 421 1 8 HELIX 27 AC9 ASP A 431 VAL A 447 1 17 HELIX 28 AD1 THR A 449 GLY A 466 1 18 HELIX 29 AD2 GLN A 472 ILE A 484 1 13 HELIX 30 AD3 ASP A 499 ALA A 502 5 4 HELIX 31 AD4 LEU A 503 ASN A 508 1 6 HELIX 32 AD5 PHE A 512 ALA A 533 1 22 HELIX 33 AD6 PRO A 538 CYS A 542 5 5 HELIX 34 AD7 SER A 547 ARG A 559 1 13 HELIX 35 AD8 PRO A 565 ASN A 572 1 8 HELIX 36 AD9 VAL A 581 PHE A 588 1 8 HELIX 37 AE1 PHE A 588 ASN A 599 1 12 SHEET 1 AA1 5 ASN B 354 ILE B 358 0 SHEET 2 AA1 5 ASN B 394 ILE B 402 -1 O ALA B 397 N LYS B 356 SHEET 3 AA1 5 TYR B 508 GLU B 516 -1 O VAL B 510 N PHE B 400 SHEET 4 AA1 5 GLY B 431 ASN B 437 -1 N ILE B 434 O VAL B 511 SHEET 5 AA1 5 THR B 376 TYR B 380 -1 N TYR B 380 O GLY B 431 SHEET 1 AA2 2 LEU B 452 ARG B 454 0 SHEET 2 AA2 2 LEU B 492 SER B 494 -1 O GLN B 493 N TYR B 453 SHEET 1 AA3 2 TYR B 473 GLN B 474 0 SHEET 2 AA3 2 CYS B 488 TYR B 489 -1 O TYR B 489 N TYR B 473 SHEET 1 AA4 2 LEU A 262 PRO A 263 0 SHEET 2 AA4 2 VAL A 487 VAL A 488 1 O VAL A 488 N LEU A 262 SHEET 1 AA5 2 THR A 347 GLY A 352 0 SHEET 2 AA5 2 ASP A 355 LYS A 359 -1 O LYS A 359 N THR A 347 SSBOND 1 CYS B 336 CYS B 361 1555 1555 2.03 SSBOND 2 CYS B 379 CYS B 432 1555 1555 2.03 SSBOND 3 CYS B 391 CYS B 525 1555 1555 2.03 SSBOND 4 CYS B 480 CYS B 488 1555 1555 2.03 SSBOND 5 CYS A 344 CYS A 361 1555 1555 2.03 SSBOND 6 CYS A 530 CYS A 542 1555 1555 2.03 LINK ND2 ASN B 343 C1 NAG B 601 1555 1555 1.44 LINK NE2 HIS A 374 ZN ZN A 701 1555 1555 2.10 LINK NE2 HIS A 378 ZN ZN A 701 1555 1555 2.10 LINK OE1 GLU A 402 ZN ZN A 701 1555 1555 2.10 LINK OE2 GLU A 402 ZN ZN A 701 1555 1555 2.10 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000